Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial.

Pickard R, Starr K, MacLennan G, Lam T, Thomas R, Burr J, McPherson G, McDonald A, Anson K, N'Dow J, Burgess N, Clark T, Kilonzo M, Gillies K, Shearer K, Boachie C, Cameron S, Norrie J, McClinton S.

Lancet. 2015 May 18. pii: S0140-6736(15)60933-3. doi: 10.1016/S0140-6736(15)60933-3. [Epub ahead of print]

PMID:
25998582
2.

Effects of tourniquet use on quadriceps function and pain in total knee arthroplasty.

Liu D, Graham D, Gillies K, Gillies RM.

Knee Surg Relat Res. 2014 Dec;26(4):207-13. doi: 10.5792/ksrr.2014.26.4.207. Epub 2014 Dec 2.

3.

Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults.

Lam TB, Omar MI, Fisher E, Gillies K, MacLennan S.

Cochrane Database Syst Rev. 2014 Sep 23;9:CD004013. doi: 10.1002/14651858.CD004013.pub4. Review.

PMID:
25248140
4.

Decision aids for randomised controlled trials: a qualitative exploration of stakeholders' views.

Gillies K, Skea ZC, Campbell MK.

BMJ Open. 2014 Aug 19;4(8):e005734. doi: 10.1136/bmjopen-2014-005734.

5.
6.

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

King MT, Stockler MR, Butow P, O'Connell R, Voysey M, Oza AM, Gillies K, Donovan HS, Mercieca-Bebber R, Martyn J, Sjoquist K, Friedlander ML.

Int J Gynecol Cancer. 2014 Jun;24(5):865-73. doi: 10.1097/IGC.0000000000000167.

PMID:
24844220
7.

Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.

Friedlander ML, Stockler M, O'Connell R, Voysey M, Oza A, Gillies K, Donovan H, Martyn J, Sjoquist K, Butow P, King MT; Symptom Benefit Study Group.

Int J Gynecol Cancer. 2014 Jun;24(5):857-64. doi: 10.1097/IGC.0000000000000147.

PMID:
24844219
9.

Determining information for inclusion in a decision-support intervention for clinical trial participation: a modified Delphi approach.

Gillies K, Skea ZC, MacLennan SJ, Ramsay CR, Campbell MK.

Clin Trials. 2013;10(6):967-76. doi: 10.1177/1740774513508339. Epub 2013 Nov 4.

PMID:
24188963
10.

Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.

Sjoquist KM, Friedlander ML, O'Connell RL, Voysey M, King MT, Stockler MR, Oza AM, Gillies K, Martyn JK, Butow PN.

Oncologist. 2013;18(11):1221-8. doi: 10.1634/theoncologist.2013-0175. Epub 2013 Oct 9.

11.

NFκB regulates expression of Polo-like kinase 4.

Ledoux AC, Sellier H, Gillies K, Iannetti A, James J, Perkins ND.

Cell Cycle. 2013 Sep 15;12(18):3052-62. doi: 10.4161/cc.26086. Epub 2013 Aug 21.

12.

Anterograde trafficking of CXCR4 and CCR2 receptors in a prostate cancer cell line.

Gillies K, Wertman J, Charette N, Dupré DJ.

Cell Physiol Biochem. 2013;32(1):74-85. doi: 10.1159/000350126. Epub 2013 Jul 5.

PMID:
23839224
13.

Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).

Pickard R, Lam T, Maclennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N'dow J.

Health Technol Assess. 2012 Nov;16(47):1-197. doi: 10.3310/hta16470.

14.

Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial.

Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N'Dow J.

Lancet. 2012 Dec 1;380(9857):1927-35. doi: 10.1016/S0140-6736(12)61380-4. Epub 2012 Nov 5.

15.

Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision.

Gillies K, Entwistle VA.

J Med Ethics. 2012 Dec;38(12):751-6. doi: 10.1136/medethics-2011-100059. Epub 2012 Aug 8.

PMID:
22875981
16.

A phase 3 trial of bevacizumab in ovarian cancer.

Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators.

N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. Erratum in: N Engl J Med. 2012 Jan 19;366(3):284.

17.

Interactions between TrkB signaling and serotonin excess in the developing murine somatosensory cortex: a role in tangential and radial organization of thalamocortical axons.

Vitalis T, Cases O, Gillies K, Hanoun N, Hamon M, Seif I, Gaspar P, Kind P, Price DJ.

J Neurosci. 2002 Jun 15;22(12):4987-5000.

18.

Fates of the earliest generated cells in the developing murine neocortex.

Price DJ, Aslam S, Tasker L, Gillies K.

J Comp Neurol. 1997 Jan 20;377(3):414-22.

PMID:
8989655
19.

Loss of plasmid-mediated oligopeptide transport system in lactococci: another reason for slow milk coagulation.

Yu W, Gillies K, Kondo JK, Broadbent JR, McKay LL.

Plasmid. 1996 May;35(3):145-55.

PMID:
8812781
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk